Pathogenesis of Pulmonary Fibrosis due to Asbestos and Silica

  • R. J. Emerson
  • E. Bateman
  • P. Cole
Part of the Ettore Majorana International Science Series book series (EMISS, volume 6)


Inhalation of silica or asbestos for a sufficient time and at a sufficient dose can lead to irreversible damage of the blood/gas barrier and pleura. As well as these particles being fibrogenic, asbestos has been shown to be associated with’increase in bronchial carcinomas and mesotheliomas (Becklake, 1976). The effects of these particles on lung is dependent on a number of variable factors — puriety, dose, physical and chemical composition and host factors which alter normal pulmonary defense mechanism: for example, existing acute or chronic inflammation, cigarette smoke, immunological status and lung anatomical variations which may cause alterations in the site of particle retention between individuals.


Pulmonary Fibrosis Mononuclear Phagocyte Asbestos Exposure Diffusion Chamber Progressive Fibrosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Allison, A.C., Experimental methods — cell and tissue culture: effects of asbestos particles on macrophages, mesothelial cells and fibroblasts, in: “Biological Effects of Asbestos, Proceedings Working Conference International Agency for Research on Cancer”, Lyon, France, October, 1972, P. Bogovski, J.C. Gilson, V. Timbrell and J.C. Wagner, eds., I.A.R.C. Scientific Publication, No.8, Lyon, 1973.Google Scholar
  2. Allison, A.C., Clark, I.A., and Davies, P., 1977, Cellular interactions in fibrogenesis, Ann. Rheum. Dis., 36:Suppl., 8–13.CrossRefGoogle Scholar
  3. Allison, A.C., Harington, J.S., and Birbeck, M., 1968, An examination of the cytotoxic effects of silica on macrophages, J. Exp. Med. 124:141.CrossRefGoogle Scholar
  4. Bateman, E.D., Emerson, R.J., and Cole, P., The use of diffusion chambers to examine the biological effects of mineral dusts, in: “Proceedings of the International Workshop on the in vitro Effects of Mineral Dusts”, Cardiff, Wales, September 4–7, 1979, in press.Google Scholar
  5. Becklake, M.R., 1976, Asbestos related diseases of the lung and other organs: their epidemiology and implications for clinical practice, Am. Rev. Respir. Dis., 114:187.PubMedGoogle Scholar
  6. Butler, C, 1975, Pulmonary interstitial fibrosis from paraquat in the hamster, Arch. Pathol., 99:563.Google Scholar
  7. Carrington, C, 1968, Organizing interstitial penumonia, definition of the lesion and attempts to devise an experimental model, Yale J. Biol. Med., 40:352.PubMedGoogle Scholar
  8. Chao, E.C.T., Fahey, J.J., and Littler, J., 1962, Stishovite, SiO2, a very high pressure new mineral from Meteor Crater, Arizona, J. Geophys. Res., 67:419.CrossRefGoogle Scholar
  9. Emerson, R.J., 1980, Cellular Interactions in Pulmonary Fibrogenesis, Ph.D. Thesis, University of London, London, England.Google Scholar
  10. Holt, P.F., Mills, J., and Young, D.K., 1964, Experimental asbestosis in the guinea-pig, J. Pathol. Bact., 92: 185.CrossRefGoogle Scholar
  11. Lehtonen, E., Nordling, S., and Wartiovaara, J., 1973, Permeability and structure of ethanol sterilized nitrocellulose (Millipore) filters, Expl. Cell. Res., 81: 169.CrossRefGoogle Scholar
  12. Richerson, H.B., Seidenfield, Ji., Ratajeyak, H.V., and Edwards, D.W., 1978, Chronic experimental interstitial pneumonitis in the rabbit, Am. Rev. Respir. Dis., 117: 5.PubMedGoogle Scholar
  13. Selikoff, I.J., and Lee, D.H., Asbestos and Disease, Academic Press, London, 1978.Google Scholar
  14. Wartiovaara, J., Lehtonen, E., Nordling, S., and Saxen, L., 1972, Do membrane filters prevent cell contacts? Nature 238: 407.CrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1982

Authors and Affiliations

  • R. J. Emerson
    • 1
  • E. Bateman
    • 1
  • P. Cole
    • 1
  1. 1.Host Defense Unit, Dept. of MedicineCardiothoracic Institute, Brompton HospitalLondonUK

Personalised recommendations